Chargement en cours...
Impact of Temozolomide on Immune Response during Malignant Glioma Chemotherapy
Malignant glioma, or glioblastoma, is the most common and lethal form of brain tumor with a median survival time of 15 months. The established therapeutic regimen includes a tripartite therapy of surgical resection followed by radiation and temozolomide (TMZ) chemotherapy, concurrently with radiatio...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Hindawi Publishing Corporation
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3486128/ https://ncbi.nlm.nih.gov/pubmed/23133490 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/831090 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|